163 related articles for article (PubMed ID: 24300044)
21. Fidaxomicin: a minimally absorbed macrocyclic antibiotic for the treatment of Clostridium difficile infections.
Soriano MM; Liao S; Danziger LH
Expert Rev Anti Infect Ther; 2013 Aug; 11(8):767-76. PubMed ID: 23977933
[TBL] [Abstract][Full Text] [Related]
22. Role of fidaxomicin for the treatment of Clostridium difficile infection.
Juang P; Hardesty JS
J Pharm Pract; 2013 Oct; 26(5):491-7. PubMed ID: 24064437
[TBL] [Abstract][Full Text] [Related]
23. Cost-effectiveness analysis on the use of fidaxomicin and vancomycin to treat Clostridium difficile infection in France.
Watt M; Dinh A; Le Monnier A; Tilleul P
J Med Econ; 2017 Jul; 20(7):678-686. PubMed ID: 28299963
[TBL] [Abstract][Full Text] [Related]
24. Successful use of fidaxomicin in recurrent Clostridium difficile infection in a child.
Smeltzer S; Hassoun A
J Antimicrob Chemother; 2013 Jul; 68(7):1688-9. PubMed ID: 23463209
[No Abstract] [Full Text] [Related]
25. The role of vancomycin and metronidazole for the treatment of Clostridium difficile-associated diarrhea.
Tart SB
J Pharm Pract; 2013 Oct; 26(5):488-90. PubMed ID: 23940121
[TBL] [Abstract][Full Text] [Related]
26. Treatment of Clostridium difficile infections.
Soriano MM; Johnson S
Infect Dis Clin North Am; 2015 Mar; 29(1):93-108. PubMed ID: 25573676
[TBL] [Abstract][Full Text] [Related]
27. Fidaxomicin versus vancomycin for Clostridium difficile infection.
Louie TJ; Miller MA; Mullane KM; Weiss K; Lentnek A; Golan Y; Gorbach S; Sears P; Shue YK;
N Engl J Med; 2011 Feb; 364(5):422-31. PubMed ID: 21288078
[TBL] [Abstract][Full Text] [Related]
28. Clostridium difficile Bacteremia in a Neonate.
Bergamo D
Clin Pediatr (Phila); 2017 Jun; 56(6):584-585. PubMed ID: 27521152
[No Abstract] [Full Text] [Related]
29. Clostridium difficile infection and proton pump inhibitors.
Pohl JF
Curr Opin Pediatr; 2012 Oct; 24(5):627-31. PubMed ID: 22781139
[TBL] [Abstract][Full Text] [Related]
30. Current and emerging management options for Clostridium difficile infection: what is the role of fidaxomicin?
Cornely OA
Clin Microbiol Infect; 2012 Dec; 18 Suppl 6():28-35. PubMed ID: 23121552
[TBL] [Abstract][Full Text] [Related]
31. Fidaxomicin for treatment of clostridium difficile-associated diarrhea and its potential role for prophylaxis.
Hostler CJ; Chen LF
Expert Opin Pharmacother; 2013 Aug; 14(11):1529-36. PubMed ID: 23683070
[TBL] [Abstract][Full Text] [Related]
32. Clostridium difficile Relapse Secondary to Medication Access Issue.
AORN J; 2015 Jul; 102(1):108, 63. PubMed ID: 26119615
[No Abstract] [Full Text] [Related]
33. Fidaxomicin (OPT-80) for the treatment of Clostridium difficile infection.
Miller M
Expert Opin Pharmacother; 2010 Jun; 11(9):1569-78. PubMed ID: 20446864
[TBL] [Abstract][Full Text] [Related]
34. Reply to M.R. Green et al.
Cornely OA; Miller MA; Fantin BR; Mullane KM; Kean Y; Gorbach SL
J Clin Oncol; 2013 Dec; 31(34):4379. PubMed ID: 24166523
[No Abstract] [Full Text] [Related]
35. Breaking the cycle of recurrent Clostridium difficile infections.
Fitzpatrick F; Barbut F
Clin Microbiol Infect; 2012 Dec; 18 Suppl 6():2-4. PubMed ID: 23121548
[No Abstract] [Full Text] [Related]
36. The efficacy of fidaxomicin in the treatment of Clostridium difficile infection in a real-world clinical setting: a Spanish multi-centre retrospective cohort.
Fehér C; Múñez Rubio E; Merino Amador P; Delgado-Iribarren Garcia-Campero A; Salavert M; Merino E; Maseda Garrido E; Díaz-Brito V; Álvarez MJ; Mensa J
Eur J Clin Microbiol Infect Dis; 2017 Feb; 36(2):295-303. PubMed ID: 27718071
[TBL] [Abstract][Full Text] [Related]
37. Antibiotic Stewardship in Paediatric Inpatients and C. Difficile Associated Disease?
Simon A; Schmid S; von Müller L
Klin Padiatr; 2017 Mar; 229(2):102. PubMed ID: 28073117
[No Abstract] [Full Text] [Related]
38. The reply.
Seifert CF; Brown AT
Am J Med; 2015 Apr; 128(4):e19. PubMed ID: 25812640
[No Abstract] [Full Text] [Related]
39. The reply.
Seifert CF; Brown AT
Am J Med; 2015 Apr; 128(4):e15. PubMed ID: 25812638
[No Abstract] [Full Text] [Related]
40. Progress with a difficult infection.
Wilcox MH
Lancet Infect Dis; 2012 Apr; 12(4):256-7. PubMed ID: 22321771
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
